Domestic drug “replevin the” company “Promomed”, which is similar to that invented in Japan drug “Favipiravir”, is used to treat novel coronavirus infection, received approval of the Ministry of health.
Relevant information published on the website of the state registry of medicines.
“Trade name of the drug “Replevin”. Or modified international point or chemical name, the “Favipiravir”. Release form — tablets film-coated. The registration date is 23 June 2020″, — stated on the website.
Earlier, Executive Director of JSC “Biochemist” Dmitry Zemskov explained TASS that “Replevin” blocks the replication of the virus in human cells, thus preventing the spread of infection in the body. The drug has efficacy against RNA viruses, including coronavirus COVID-19. In applying the drug significantly reduced the time of infection in the body — almost up to 4 days.
First registered in Russia drug on the basis of favipiravir was “Aviewer” produced by the Russian direct investment Fund and the group of companies “Chemrar”.
More Stories
Color wheel online
The Ministry of health has promised to disclose information about the vaccine trials from COVID-19
Called “atypical” symptoms of coronavirus